Affluent Medical S.A.
AFME.PA · PAR
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | – | €53 | €52 | €56 |
| - Cash | €5 | €1 | €1 | €2 |
| + Debt | €21 | €16 | €18 | €17 |
| Enterprise Value | – | €68 | €68 | €72 |
| Revenue | €1 | €4 | €1 | €1 |
| % Growth | -86% | 523% | 4.3% | – |
| Gross Profit | -€1 | -€3 | -€0 | -€1 |
| % Margin | -197.9% | -80.2% | -66.6% | -96.7% |
| EBITDA | -€8 | -€5 | -€8 | -€7 |
| % Margin | -1,404.9% | -125.7% | -1,250.5% | -1,095.4% |
| Net Income | -€9 | -€5 | -€9 | -€8 |
| % Margin | -1,624.3% | -130.4% | -1,417.2% | -1,210.3% |
| EPS Diluted | -0.24 | -0.14 | -0.29 | -0.25 |
| % Growth | -71.4% | 51.7% | -16% | – |
| Operating Cash Flow | -€7 | -€8 | -€4 | -€4 |
| Capital Expenditures | -€0 | €0 | -€0 | -€0 |
| Free Cash Flow | -€7 | -€8 | -€4 | -€4 |